RHYTHM PHARMACEUTICALS INC shareholders Q3 2023

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

RHYTHM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Swiss National Bank 99,900$2,290,2070.00%
Mirae Asset Global Investments Co., Ltd. 30,333$695,3840.00%
VANGUARD GROUP INC 3,014,568$69,108,9720.00%
ADAGE CAPITAL PARTNERS GP, L.L.C. 43,815$1,004,4590.00%
BNP PARIBAS FINANCIAL MARKETS 55,243$1,266,4460.00%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 20,367$466,9130.00%
FMR LLC 868,474$19,909,7660.00%
NORTHERN TRUST CORP 504,022$11,554,7050.00%
AMALGAMATED BANK 7,789$1790.00%
VOYA INVESTMENT MANAGEMENT LLC 84,259$1,931,6370.00%
MORGAN STANLEY 436,408$10,004,6530.00%
Nuveen Asset Management, LLC 141,585$3,245,8360.00%
Tower Research Capital LLC (TRC) 944$21,6420.00%
Newbridge Financial Services Group, Inc. 65$1,4900.00%
AQR Capital Management 20,296$465,2860.00%
VICTORY CAPITAL MANAGEMENT INC 20,050$459,6460.00%
Focused Wealth Management, Inc 300$6,8780.00%
JANE STREET GROUP, LLC 144,002$3,301,2450.00%
ALLIANCEBERNSTEIN L.P. 54,390$1,246,8910.00%
UBS OCONNOR LLC 45,000$49,5000.00%
External links

This page lists RHYTHM PHARMACEUTICALS INC's shareholders in Q3 2023. To view RHYTHM PHARMACEUTICALS INC's shareholder history, click here.